Diag2Tec – Preclinical CRO in Multiple Myeloma, Lymphoma, Leukemia
  • Home
  • Our Expertise
    • Multiple Myeloma
    • Hematological Cancer Cell Lines from Patients
    • Primary Samples from Hematological Malignancies
    • In Vitro Model of Human Plasma Cell Differentiation
    • Flow Cytometry
    • NGS – Biomarkers – New Therapeutic Targets Identification
  • Preclinical Services
    • In vitro Drug Testing
    • Immunotherapies : Assays and Analyses
    • Prognosis and Predictive Biomarkers
  • About us
    • Team & History
    • Prospects and Partners
    • ISO 9001: 2015 Certification
  • Press & Events
    • List of Publications and Patents
    • Diag2Tec Publications and Posters
    • Meet our team
  • Contact
    • Contact us
    • Opportunities
logo

Our News

Home → Our News

The publication’s team in the front cover of Theranostics journal

February 5, 2019 / News

Diag2Tec s’attaque au myélome multiple

November 14, 2018 / News

Diag2Tec présente son pitch aux investisseurs lors du salon Occitanie Invest

November 10, 2018 / News

BioPharlAnalyses

May 28, 2018 / News

Montpellier’s BIC

February 2, 2018 / News

2017 Annual Congress of American Society of Hematology

December 9, 2017 / News

Midi Libre Newspaper

June 28, 2017 / News

Diag2Tec lauréat du concours i-Lab

July 28, 2016 / News

i-Lab 2016 : Catégorie Création-développement

July 25, 2016 / News

Diag2Tec visit in Florida

May 23, 2016 / News

Interview of Jerome Moreaux, Diag2Tec’s CSO

November 4, 2015 / News

Diag2Tec soutenue par Crealia

June 18, 2015 / News

Jérôme Moreaux Lauréat Chercheur D’avenir 2013

February 5, 2013 / News

Diag2Tec’s Headquarters

Immeuble le Stratège
1095 rue Henri Becquerel
34000 Montpellier FRANCE

Diag2Tec’s Laboratories

CHU St Eloi, Dpt Hematology Biology
80 Av Augustin Fliche
34295 Montpellier FRANCE
Diag2Tec logo

  Contact us

Documentation

Services brochure
Publications and Patents
ISO 9001 Certification

Preclinical Services

In vitro Drug Testing
Immunotherapies : Assays and Analysis
Prognosis and Predictive Biomarkers
© Diag2Tec all rights reserved - Legal Notice & Confidentiality - Cookie policy
Back to Top
Manage Cookie Consent
To provide the best experiences, we use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us to process data such as browsing behavior or unique IDs on this site. Not consenting or withdrawing consent, may adversely affect certain features and functions.
Functional Always active
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
Preferences
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
Statistics
The technical storage or access that is used exclusively for statistical purposes. The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
Marketing
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.
Manage options Manage services Manage {vendor_count} vendors Read more about these purposes
View preferences
{title} {title} {title}